Literature DB >> 20890131

Global methylation profiles in DNA from different blood cell types.

Hui-Chen Wu1, Lissette Delgado-Cruzata, Julie D Flom, Maya Kappil, Jennifer S Ferris, Yuyan Liao, Regina M Santella, Mary Beth Terry.   

Abstract

DNA methylation measured in white blood cell DNA is increasingly being used as in studies of cancer susceptibility. However, little is known about the correlation between different assays to measure global methylation and whether the source of DNA matters when examining methylation profiles in different blood cell types. Using information from 620 women, 217 and 403 women with DNA available from granulocytes (Gran), and total white blood cells (WBC), respectively, and 48 women with DNA available from four different sources (WBC, Gran, mononuclear (MN), and lymphoblastoid cell lines (LCL)), we compared DNA methylation for three repetitive elements (LINE1, Sat2, Alu) by MethyLight, luminometric methylation assay (LUMA), and [(3)H]-methyl acceptance assay. For four of the five assays, DNA methylation levels measured in Gran were not correlated with methylation in LBC, MN, or WBC; the exception was Sat2. DNA methylation in LCL was correlated with methylation in MN and WBC for the [(3)H]-methyl acceptance, LINE1, and Alu assays. Methylation in MN was correlated with methylation in WBC for the [(3)H]-methyl acceptance and LUMA assays. When we compared the five assays to each other by source of DNA, we observed statistically significant positive correlations ranging from 0.3-0.7 for each cell type with one exception (Sat2 and Alu in MN). Among the 620 women stratified by DNA source, correlations among assays were highest for the three repetitive elements (range 0.39-0.64). Results from the LUMA assay were modestly correlated with LINE1 (0.18-0.20). These results suggest that both assay and source of DNA are critical components in the interpretation of global DNA methylation patterns from WBC.

Entities:  

Mesh:

Year:  2011        PMID: 20890131      PMCID: PMC3052916          DOI: 10.4161/epi.6.1.13391

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  46 in total

1.  Chromosomal instability and tumors promoted by DNA hypomethylation.

Authors:  Amir Eden; François Gaudet; Alpana Waghmare; Rudolf Jaenisch
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

2.  DNA methylation and diet in cancer.

Authors:  Gary L Johanning; Douglas C Heimburger; Chandrika J Piyathilake
Journal:  J Nutr       Date:  2002-12       Impact factor: 4.798

3.  Comprehensive high-throughput arrays for relative methylation (CHARM).

Authors:  Rafael A Irizarry; Christine Ladd-Acosta; Benilton Carvalho; Hao Wu; Sheri A Brandenburg; Jeffrey A Jeddeloh; Bo Wen; Andrew P Feinberg
Journal:  Genome Res       Date:  2008-03-03       Impact factor: 9.043

Review 4.  Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer.

Authors:  S B Baylin; M Esteller; M R Rountree; K E Bachman; K Schuebel; J G Herman
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

5.  Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers.

Authors:  Jairo Rodriguez; Jordi Frigola; Elisenda Vendrell; Rosa-Ana Risques; Mario F Fraga; Cristina Morales; Victor Moreno; Manel Esteller; Gabriel Capellà; Maria Ribas; Miguel A Peinado
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

6.  Genomic DNA methylation among women in a multiethnic New York City birth cohort.

Authors:  Mary Beth Terry; Jennifer S Ferris; Richard Pilsner; Julie D Flom; Parisa Tehranifar; Regina M Santella; Mary V Gamble; Ezra Susser
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

Review 7.  Human satellites 2 and 3.

Authors:  M Jeanpierre
Journal:  Ann Genet       Date:  1994

Review 8.  Mobile elements and mammalian genome evolution.

Authors:  Prescott L Deininger; John V Moran; Mark A Batzer; Haig H Kazazian
Journal:  Curr Opin Genet Dev       Date:  2003-12       Impact factor: 5.578

9.  Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.

Authors:  Lee E Moore; Ruth M Pfeiffer; Cristina Poscablo; Francisco X Real; Manolis Kogevinas; Debra Silverman; Reina García-Closas; Stephen Chanock; Adonina Tardón; Consol Serra; Alfredo Carrato; Mustafa Dosemeci; Montserrat García-Closas; Manel Esteller; Mario Fraga; Nathaniel Rothman; Núria Malats
Journal:  Lancet Oncol       Date:  2008-03-12       Impact factor: 41.316

10.  Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation.

Authors:  A R Florl; C Steinhoff; M Müller; H-H Seifert; C Hader; R Engers; R Ackermann; W A Schulz
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

View more
  77 in total

1.  Genomic methylation changes over time in peripheral blood mononuclear cell DNA: differences by assay type and baseline values.

Authors:  Hui-Chen Wu; Qiao Wang; Lissette Delgado-Cruzata; Regina M Santella; Mary Beth Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-04       Impact factor: 4.254

2.  DNA methylation screening and analysis.

Authors:  Karilyn E Sant; Muna S Nahar; Dana C Dolinoy
Journal:  Methods Mol Biol       Date:  2012

Review 3.  DNA methylation in white blood cells: association with risk factors in epidemiologic studies.

Authors:  Mary Beth Terry; Lissette Delgado-Cruzata; Neomi Vin-Raviv; Hui Chen Wu; Regina M Santella
Journal:  Epigenetics       Date:  2011-07-01       Impact factor: 4.528

Review 4.  Epigenetics, epidemiology and mitochondrial DNA diseases.

Authors:  Patrick F Chinnery; Hannah R Elliott; Gavin Hudson; David C Samuels; Caroline L Relton
Journal:  Int J Epidemiol       Date:  2012-01-28       Impact factor: 7.196

5.  Adult global DNA methylation in relation to pre-natal nutrition.

Authors:  L H Lumey; Mary Beth Terry; Lissette Delgado-Cruzata; Yuyan Liao; Qiao Wang; Ezra Susser; Ian McKeague; Regina M Santella
Journal:  Int J Epidemiol       Date:  2011-09-29       Impact factor: 7.196

6.  Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples.

Authors:  Dana van Bemmel; Petra Lenz; Linda M Liao; Dalsu Baris; Lawrence R Sternberg; Andrew Warner; Alison Johnson; Michael Jones; Masatoshi Kida; Molly Schwenn; Alan R Schned; Debra T Silverman; Nathaniel Rothman; Lee E Moore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-04-26       Impact factor: 4.254

7.  White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population.

Authors:  Fang Fang Zhang; Regina M Santella; Mary Wolff; Maya A Kappil; Steven B Markowitz; Alfredo Morabia
Journal:  Epigenetics       Date:  2012-06-01       Impact factor: 4.528

8.  Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study.

Authors:  Hui-Chen Wu; Qiao Wang; Hwai-I Yang; Wei-Yann Tsai; Chien-Jen Chen; Regina M Santella
Journal:  Carcinogenesis       Date:  2012-05-12       Impact factor: 4.944

9.  LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants.

Authors:  Gabriella Andreotti; Sara Karami; Ruth M Pfeiffer; Lauren Hurwitz; Linda M Liao; Stephanie J Weinstein; Demetrius Albanes; Jarmo Virtamo; Debra T Silverman; Nathaniel Rothman; Lee E Moore
Journal:  Epigenetics       Date:  2013-12-06       Impact factor: 4.528

10.  Types of DNA methylation status of the interspersed repetitive sequences for LINE-1, Alu, HERV-E and HERV-K in the neutrophils from systemic lupus erythematosus patients and healthy controls.

Authors:  Patadon Sukapan; Paramate Promnarate; Yingyos Avihingsanon; Apiwat Mutirangura; Nattiya Hirankarn
Journal:  J Hum Genet       Date:  2014-01-16       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.